Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07852416 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Electronic PHES vs Paper-based PHES for Hepatic Encephalopathy

StatusNot Yet Recruiting
PhaseNot applicable
Started2026-10-01
View on ClinicalTrials.gov ↗
This is a prospective, multicenter, randomized crossover diagnostic accuracy study. A total of 80 patients with liver cirrhosis will be enrolled and randomly assigned to two sequence groups at a 1:1 ratio. Participants in Sequence A will complete the paper-based Psychometric Hepatic Encephalopathy Score (PHES) on Day 1 and the electronic PHES on Day 2; participants in Sequence B will receive the tests in reverse order. All tests will be performed at the same time of day with a 1-day washout interval to minimize carryover effect. The primary objective is to verify the equivalence of total scores between electronic and paper-based PHES. Secondary objectives include evaluating the consistency of MHE classification and individual subtest scores, and analyzing the effects of test sequence and time period on results. This study aims to provide evidence for clinical promotion of the electronic PHES tool.
Trial Details
NCT Number NCT07852416
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Conditions Liver Cirrhosis, Hepatic Encephalopathy, Minimal Hepatic Encephalopathy
Enrollment 80 participants
Start Date 2026-10-01
Primary Completion 2027-09-01 (estimated)
Study Completion 2027-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-10-01